Imago BioSciences (IMGO) News Today → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free IMGO Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineClarus Lifesciences III, L.P.'s Net Worthbenzinga.com - February 23 at 3:04 PMAnixa Biosciences Inc ANIXmorningstar.com - December 21 at 10:46 PMHarmony Biosciences shares are trading lower after the company reported Q4 financial results.benzinga.com - February 23 at 9:00 PMMerck To Complete Acquisition Of Imagomarkets.businessinsider.com - January 11 at 10:01 AMMerck Completes Tender Offer to Acquire Imago BioSciences, Inc.finance.yahoo.com - January 11 at 10:01 AMmarketbeat.com - January 11 at 6:15 AMLooking Into Imago BioSciences's Recent Short Interestmsn.com - January 4 at 3:22 PMMerck is best performing large U.S. pharma of 2022seekingalpha.com - December 30 at 1:33 PMLaura G. Eichorn Sells 3,100 Shares of Imago BioSciences, Inc. (NASDAQ:IMGO) Stockmarketbeat.com - December 29 at 6:17 PMImago BioSciences, Inc. (NASDAQ:IMGO) Given Average Recommendation of "Hold" by Analystsmarketbeat.com - December 23 at 3:11 AMImago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 2 Study of Bomedemstat in Combination with Ruxolitinib in Myelofibrosisfinance.yahoo.com - December 20 at 6:26 PMImago BioSciences, Inc. (NASDAQ:IMGO) Insider Jennifer Peppe Sells 119,422 Sharesmarketbeat.com - December 19 at 6:13 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ELVT, IMGO, GRAY, USERmarkets.businessinsider.com - December 13 at 3:25 PMImago BioSciences, Inc. (NASDAQ:IMGO) Short Interest Down 79.4% in Novembermarketbeat.com - December 12 at 8:55 PMImago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Advanced Myelofibrosis at ASH 2022finance.yahoo.com - December 12 at 5:17 PMImago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2022finance.yahoo.com - December 12 at 5:17 PMMerck Commences Tender Offer To Acquire Imago BioSciencesmarkets.businessinsider.com - December 12 at 7:39 AMHow Is The Market Feeling About Imago BioSciences?msn.com - December 9 at 4:41 PMImago BioSciences: The Bone Marrow Cancer Researcher Reaches Milestoneseekingalpha.com - November 30 at 9:36 PMImago BioSciences Announces First Participant Dosed in Investigator-Sponsored Phase 1 Study of Bomedemstat in Combination with Venetoclax in Relapsed/Refractory Acute Myeloid Leukemiafinance.yahoo.com - November 30 at 9:36 PMHorizon Therapeutics Fields Takeover Interest From Pharma Giantsfinance.yahoo.com - November 29 at 5:46 PMSHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Imago BioSciences, Inc. - IMGObenzinga.com - November 29 at 12:29 AMAnalyst Ratings for Imago BioSciencesmarkets.businessinsider.com - November 28 at 7:29 PMImago BioSciences (NASDAQ:IMGO) Lowered to Hold at Stifel Nicolausmarketbeat.com - November 28 at 7:48 AMPharma Stock Roundup: MRK to Buy IMGO, ABBV's Skyrizi Gets EU Nod for New Indicationfinance.yahoo.com - November 25 at 1:49 PMImago Bio Shares Soar on Agreement to Selll to Merck for $1.35 Billion Cash247wallst.com - November 24 at 11:53 AMImago BioSciences, Inc. (NASDAQ:IMGO) Forecasted to Post Q2 2023 Earnings of ($0.63) Per Sharemarketbeat.com - November 24 at 8:48 AMImago BioSciences, Inc. Expected to Post Q1 2023 Earnings of ($0.57) Per Share (NASDAQ:IMGO)marketbeat.com - November 23 at 7:30 AMExpert Ratings for Imago BioSciencesmarkets.businessinsider.com - November 22 at 4:53 PMWhat 5 Analyst Ratings Have To Say About Imago BioSciencesmarkets.businessinsider.com - November 22 at 4:53 PMImago (IMGO) Shares Surge 104% on Buyout Offer From Merckfinance.yahoo.com - November 22 at 4:53 PMImago BioSciences' (IMGO) "Neutral" Rating Reaffirmed at HC Wainwrightmarketbeat.com - November 22 at 8:30 AMMerck Eyes Expanded Blood Disorder Drug Pipeline Via $1.35 Billion Buyout of Imago BioSciencesmsn.com - November 21 at 3:20 PMCancer-Focused Imago BioSciences Shares Soar After Merck Dealfinance.yahoo.com - November 21 at 3:20 PMImago BioSciences Reports Third Quarter 2022 Financial Results and Provides Recent Business Updatesca.finance.yahoo.com - November 21 at 10:20 AMMerck to Buy Imago, Shares Gainbaystreet.ca - November 21 at 10:20 AMDisney, Imago BioSciences rise premarket; Coinbase, Carvana fallmsn.com - November 21 at 10:20 AMImago BioSciences Shares Take Flight on Takeover by Merck >IMGOmarketwatch.com - November 21 at 10:20 AMIMGO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Imago BioSciences, Inc. Is Fair to Shareholderstechnews.tmcnet.com - November 21 at 10:20 AMMerck to buy Imago Biosciences for $1.35 billionfinance.yahoo.com - November 21 at 10:20 AMImago BioSciences Stock Surges. It’s Being Bought by Merck.finance.yahoo.com - November 21 at 10:20 AMImago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyoutfinance.yahoo.com - November 21 at 10:20 AMImago BioSciences, Inc. (NASDAQ:IMGO) Forecasted to Earn FY2022 Earnings of ($1.94) Per Sharemarketbeat.com - November 14 at 2:13 AMImago BioSciences Reports Third Quarter 2022 Financial Results and Provides Recent Business Updatesfinance.yahoo.com - November 9 at 4:23 PMAmy E. Tapper Sells 750 Shares of Imago BioSciences, Inc. (NASDAQ:IMGO) Stockmarketbeat.com - November 4 at 9:14 PMImago BioSciences Announces Oral Data Presentations at the Upcoming 64th American Society of Hematology Annual Meeting and Expositionfinance.yahoo.com - November 3 at 1:39 PMWe Think Imago BioSciences (NASDAQ:IMGO) Can Afford To Drive Business Growthnasdaq.com - October 11 at 2:23 PMImago BioSciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - September 6 at 8:39 PMWall Street Analysts Think Imago BioSciences, Inc. (IMGO) Could Surge 83%: Read This Before Placing a Betfinance.yahoo.com - August 19 at 1:41 PMImago BioSciences, Inc. (NASDAQ:IMGO) Insider Amy E. Tapper Sells 750 Sharesmarketbeat.com - August 16 at 5:42 PM Get Imago BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IMGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Major Elon Musk Crypto Leak Revealed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. IMGO Media Mentions By Week IMGO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMGO News Sentiment▼0.000.60▲Average Medical News Sentiment IMGO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMGO Articles This Week▼00▲IMGO Articles Average Week Get Imago BioSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IMGO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: LGND News LQDA News DCPH News MIRM News BLTE News VRNA News COLL News IRWD News XNCR News SAGE News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMGO) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders Alliance“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBuy this small stock before coming AI Tidal WaveChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imago BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.